Opiant Pharmaceuticals spiked 46 percent Thursday when President Donald Trump declared a crackdown on opioid abuse.
Opiant Pharmaceuticals spiked 46 percent Thursday when President Donald Trump declared a crackdown on opioid abuse.
“We’re going to be spending lots of money on coming up with a non-addictive solutions,” Trump said during a press conference.
The company develops opioid antagonists to treat substance abuse and addiction, including NARCAN Nasal Spray, the first and only Food and Drug Administration approved spray to reverse opioid overdoses.
